Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio (2011 - 2025)

Supernus Pharmaceuticals (SUPN) has 15 years of Interest Coverage Ratio data on file, last reported at 0.97 in Q4 2025.

• On a quarterly basis, Interest Coverage Ratio fell 118.35% year-over-year to 0.97 in Q4 2025; TTM through Dec 2025 was 3.86, a 159.79% decrease from a year earlier, with the FY2025 full-year figure at 0.11, down 108.62% from the prior year.
• Interest Coverage Ratio for Q4 2025 stood at 0.97, up from 1309.37 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for SUPN reached as high as 381.73 in Q3 2024 and fell as low as 1309.37 in Q3 2025.
• Historically, Interest Coverage Ratio has averaged 44.7 across 5 years, with a median of 1.03 in 2021.
• On a YoY basis, Interest Coverage Ratio climbed as much as 5608.89% in 2023 and fell as far as 12858.2% in 2023.
• Year by year, Interest Coverage Ratio stood at 1.03 in 2021, then surged by 1996.02% to 21.54 in 2022, then slumped by 109.86% to 2.12 in 2023, then jumped by 348.32% to 5.27 in 2024, then sank by 118.35% to 0.97 in 2025.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.97 in Q4 2025, 1309.37 in Q3 2025, and 55.69 in Q2 2025.